Sage Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$438K Sell
8,868
-496
-5% -$25.2K 0.17% 106
2026
Q1
$500K Buy
9,364
+168
+2% +$9.87K 0.23% 85
2025
Q4
$572K Buy
9,196
+1
+0% +$62 0.26% 78
2025
Q3
$552K Buy
9,195
+8
+0.1% +$489 0.25% 82
2025
Q2
$575K Sell
9,187
-108
-1% -$6.49K 0.28% 75
2025
Q1
$559K Buy
9,295
+5
+0.1% +$311 0.3% 73
2024
Q4
$542K Sell
9,290
-1,074
-10% -$63.8K 0.27% 82
2024
Q3
$614K Buy
10,364
+11
+0.1% +$628 0.29% 76
2024
Q2
$580K Buy
10,353
+8
+0.1% +$448 0.3% 74
2024
Q1
$606K Buy
10,345
+3
+0% +$169 0.33% 74
2023
Q4
$558K Buy
+10,342
New +$505K 0.33% 75

Other funds holding IHI

Sage Capital Management's IHI Position: Q2 2026 in Review

Sage Capital Management reduced its iShares US Medical Devices ETF (IHI) stake by 5.3% in Q2 2026, selling an estimated $25.2K and leaving 8,868 shares worth $438K. The position accounts for 0.17% of the portfolio, ranked #106.

Sage Capital Management first reported a position in IHI in Q4 2023 and has held it in 11 quarters since. The position peaked at $614K in Q3 2024. 146 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Sage Capital Management held 8,868 shares of iShares US Medical Devices ETF worth $438K as of Q2 2026.
  • Sage Capital Management sold 496 iShares US Medical Devices ETF shares in Q2 2026, an estimated $25.2K.
  • iShares US Medical Devices ETF made up 0.17% of Sage Capital Management's portfolio in Q2 2026, its #106 holding.
  • Sage Capital Management first reported a position in iShares US Medical Devices ETF in Q4 2023 and has held it in 11 quarters since.
  • Sage Capital Management's iShares US Medical Devices ETF position peaked at $614K in Q3 2024.
  • 146 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Sage Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.